Party insiders and backroom deals: One author on why we need to bring back old-time politics.
Guest Host: Frank Sesno
An examination of the Vioxx drug scandal, whether it could happen again, and how consumers can protect themselves.
- Bert Rein a partner at Wiley Rein, who argued the Wyeth v. Levine case up through the Vermont Supreme Court.
- Ted Mayer a partner at Hughes Hubbard & Reed, who has been involved with the Vioxx litigation from the beginning.
- Tom Nesi a "patient advocate" for the FDA and former pharmaceutical executive, including a consultant for Merck.
- Gardiner Harris science reporter for "The New York Times"
Most Recent Shows
With a now-likely U.K. exit from the EU, America’s relationship with a key intelligence and global trade ally will change. Please join us to discuss what the British vote means for the U.S. economy, the 2016 presidential campaign and global security.
Analysis of the Supreme Court's last decisions of the term and the impact of a vacant seat on the bench.
The world reacts to Brexit: European Union leaders plan for Great Britain's departure and investors brace for more uncertainty, as the U.S. considers economic and strategic implications.